Abstract The genome-wide linkage disequilibrium screen for loci associated with genetic difference between allergic and nonallergic asthma was conducted with 763 autosomal STR markers and included 190 asthmatic children. Evidence for association with differences between the two forms of asthma was observed for 36 STR markers. Marker-to-marker synergetic effect and by simulation resampling tests revealed D5S2011, D6S305, and D9S286 were important loci in allergic asthma while D6S1574, D8S1769, and D19S226 were important in nonallergic asthma. Our results show strong genetic evidence that these markers play an important role in defining allergic and nonallergic asthma and provides important candidates of susceptible genes in these two categories of asthma. This study further shows that asthma is, indeed, a heterogeneous group of underlying diseases and, although with similar clinical phenotypes, may have different clinical severities, outcomes, and need more tailor-made management.
Introduction
Asthma is a chronic airway inflammatory disease, affects nearly 155 million individuals worldwide, and is a multifactorial complex disease and phenotypically heterogeneous (Cookson 1999) . Children who suffered from asthmatic diseases are more prone to have sensitized allergens detected by skin prick tests and/or by total and allergen-specific IgE antibodies in the serum, hence the extrinsic or allergic asthma. The timing and degree of allergen sensitization and total serum IgE levels are also the major determinants for the clinical severity of allergic asthma. Nonallergic asthma, or intrinsic asthma, another group of asthmatic patients, is not demonstrably allergic to common allergens by skin prick test. Serum total IgE concentrations are usually within normal ranges. These patients are usually older than their allergic counterparts and have onset of symptoms in later life, often with a more severe clinical course. There is a predominance in the female gender, and association of nasal polyps and aspirin sensitivity occurs more frequently in the nonallergic asthmatic (Rackeman 1947; Bentley et al. 1992; Humbert et al. 1996a Humbert et al. , 1999 . From these distinctive clinical manifestations, although the pathological findings are similar, nonallergic asthma is viewed as a different entity to allergic asthma.
In contrast, some authors have argued that intrinsic asthmatics are allergic to an as yet undetected allergen and suggest a role for IgE and atopy in nonallergic asthma and they could, therefore, benefit from allergen avoidance, as previously demonstrated in atopic asthmatics (Dorward et al. 1988; Burrows et al. 1989) . Analysis of bronchial mucosal expression of ''proeosinophilic'' and ''pro-atopic'' markers, i.e., IL-3, IL-4, IL-5, IL-13, GM-CSF, RANTES, MCP-3, IgE, and FcRI, demonstrates that there are more similarities than differences in immunopathology between allergic and nonallergic asthma (Humbert et al. 1996a (Humbert et al. , 1996b (Humbert et al. , 1997a (Humbert et al. , 1997b Ying et al. 1997 Ying et al. , 1999 ). The only difference seems to be a strong macrophage signal in biopsies from nonallergic asthma patients compared with those from allergic asthmatics. This could represent macrophage dysfunction or simply be a reflection of age Fig. 1 Result of entire autosomal region screened for loci associated with the differences between asthmatics with high IgE and normal IgE. Tested loci (STR markers) are arranged by number from pterminus to q-terminus in each chromosome. The graphic representation shows the allelic association on 22 autosomal chromosomes. X-axis is STR marker's genetic location on chromosome 5 from p-terminus to q-terminus. Y-axis is natural logarithm of Monte-Carlo simulation p value. Y = 3 is almost equal to p = 0.05. The numbers in the X-axis indicate the genetic location of significant loci and length of disease rather than a basic difference in the pathological mechanism between these two forms of asthma . But still, these findings cannot fully explain why nonallergic asthma, without elevation of total serum IgE, has a similar pattern of allergen-induced bronchial inflammation, either in the underlined etiology or in the disease development of this form of asthma.
Recently, Holgate and Davies (2001) postulated that epithelial damage and allergy-prone T H 2 cytokines can act in concert to cause a functional disturbance of the epithelial-mesenchymal trophic unit (EMTU), which leads to myofibroblast activation and induction of inflammatory and remodeling responses characteristic of chronic asthma (Holgate and Davies 2001) . This model differs from the traditional sequential view of asthma pathogenesis by setting the structural abnormalities in parallel with T H 2 cytokine-induced inflammation. Because allergic diseases, including asthma, rhinitis, and eczema, are caused by both environmental and genetic factors, the expression of allergic asthma is dependent on inheritance of local susceptibility genes, which have the potential to interact with the atopy predisposition, whereas nonallergic asthma may have a different set of responsible genes to the environmental stimuli that lead to EMTU damage and chronic airway inflammation in the absence of IgE elevation (Davies et al. 2003) .
Based on this hypothesis, the aim of the present study was to investigate whether there is a different set(s) of susceptible genes between allergic and nonallergic asthma in children based on total serum IgE levels and responsiveness to common aeroallergen. We conducted a genome scan using 763 autosomal STR markers to search the loci associated with these two types of asthma in Taiwanese, non-obviously related, children selected by narrow phenotype definitions. Our data revealed evidence of genetic differences between allergic and nonallergic asthma. The results implied chronic asthma initiated from allergy and/or nonallergy factors was determined by different susceptibility genes.
Materials and methods

Clinical sample collection
Our study population consisted of asthmatic children aged between 1 and 12 years old, and the Ethical and Clinical Trial Committee of the National Cheng-Kung University Hospital approved this study protocol. All participants or their guardian, after being well informed of the study protocol and signing the consent forms, answered a modified British Medical Society respiratory questionnaire, which is exactly the same as the European Community Respiratory Health Survey (ECHRS), which has similar validity as the ISAAC (Burney et al.1994; Pearce et al. 2000) , as well as additional questions pertinent to the diagnosis and assessment of asthma. Pulmonary function was tested using standard methods, which included spirometry before and after the administration of two puffs of inhaled salbutamol (200 lg/puff). The definition of asthma included: (1) History of wheezing and shortness of breath during or without concurrent respiratory infections, (2) chronic cough for more than 1 month and being diagnosed by a physician of the presence of wheezing episode(s), (3) bronchodilator test that confirmed the positive response of an increase of 15% in forced expiratory volume in 1 s (FEV1). Other evaluations included skin prick tests for responsiveness to six common aeroallergens, a differential blood count (including total eosinophil count), and measures of total serum IgE, as well as IgE specific to house dust and mixed pollens using the Unicap system (Pharmacia Diagnostic, Sweden). A positive skin test was defined as the presence of ‡1 reaction with a wheal diameter ‡5 mm. Total serum IgE was measured by solid-phase immunoassay (Pharmacia IgE EIA; Pharmacia Diagnostics). The confirmed asthmatic children were further divided by their serum IgE levels: the allergic group (105 subjects) had high IgE serum concentrations ( ‡1,000 IU/ml) and sensitized to at lease one aeroallergen; in the nonallergic group (85 subjects), IgE serum levels were within normal range ( £ 200 IU/ml), and there was no detectable allergen sensitization.
DNA preparation
Genomic DNAs were extracted from 190 unrelated Taiwanese children. DNA was isolated from blood sample using QIAamp DNA blood kit according to the manufacture's instructions. The isolated genomic DNA was quality-checked by agarose gel electrophoresis analysis, the quantity was determined spectrophotometrically, and it was stored at À80°C.
Microsatellite genotyping
Genotyping was performed using the ABI PRISM Linkage Mapping Sets HD-5 (811 markers) to provide coverage of human genome at 5 cM average resolution. Each marker set included a fluorescence-labeled forward primer and a tailing reverse primer. The PCR amplifications were carried out according to the manufacturer's instructions. The PCR products were separated on ABI 3700 DNA analyzers. The use of GeneScan 500 LIZ as the internal size standard assisted polymorphic fragment-length calling and allowed more accurate allele calling and unambiguous comparison of data across experimental conditions. Genotypes were initially scored using Genescan and Genotyper (ABI) software and were then verified independently by three individuals without prior knowledge of phenotype.
Statistical analysis
To evaluate STR markers associated with the difference between IgE-high and IgE-normal asthmatics, the STR markers with significantly different allele frequencies in two asthma subtypes were sought by v 2 test, in which the significant level was estimated by Monte-Carlo simulation (Sham and Curtis 1995) . Alleles in significant marker loci were tested for linkage disequilibrium with null causative or signature polymorphism by analysis with the contingency table. The significant alleles were tested by odds ratio as risk factors. Genotype contingency tables were constructed according to specific alleles with significant p values and odds ratio. The meaningful genotypes were defined by significant v 2 and odds ratio. Information on the genotype of all significant markers was collected, and the data set was transformed into a binary category, with the meaningful genotype and the others represented by ''1'' and ''0,'' respectively. In other words, a genotype showing association (meaningful genotype) was coded 1, and a genotypes showing no association was coded 0 in the binary data set. Discrimination equation was performed by logistic regression using the transformed binary data set.
For elucidating marker-marker synergetic effect to asthma subtype, the binary information of each of the two markers was combined as a single factor. Three categories were generated by combining two markers: both were risk genotypes, one of the two was a risk genotype, and neither was a risk genotype. The association between marker-to-marker synergetic effect and IgE status was tested by 2·3 contingency table using Fisher's exact test. Odds ratios of two-marker synergetic effect were generated using both and neither risk genotypes. If the two genes were synergetic, the odds ratio was significantly higher than only one each of the gene's odds ratio. It was shown that interaction between two genes caused multiplicative or additive risks (Szklo and Nieto 2000) . According the Slutsky's theorem, the distribution of odds ratio via natural logarithm transformed was converged to normal distribution (Agresti 2002) . In our data, the standard deviation was less then 1. The critical values of 95% of standard normal distribution with mean 0 and standard deviation 1 are +1.96 and À1.96. The values 7.1 and 0.14, the natural exponential of +1.96 and À1.96, were significant thresholds of defining multiplicative risks. All statistical analyses were performed by SAS software (SAS 8.0, SAS Inc.) Results STR markers associated with significant difference between allergy and nonallergy asthma Briefly described the Fig. 1 is the result of the whole autosomal genome region screened for loci associated with differences between allergic and nonallergic asthmatics. Normal and high IgE may be consistent with allergic and nonallergic asthma, as defined in the Material and methods section. Thirty-six STR markers were sought by allele and/or genotype frequency with significantly different IgE high and IgE normal groups (Table 1 ). The alleles of each locus were tested to odds ratio and 2·2 v 2 (data not shown) with other alleles of a Bold indicates synergetic odds ratio smaller than 0.14 or larger than 7.1 the same locus. In Table 1 , the ''Associated allele test'' lists the alleles, which were statistically significant in the test. Eight loci-for example, D5S2011-have more than one associated allele. The genotypes of each associated allele were classified as homozygous and heterozygous then tested with odds ratio and 2·2 contingency table analysis (data not shown) with other genotypes of the same locus. The test results are shown in ''Meaningful genotype test'' in Table 1 . Eighteen meaningful genotypes are shown in the dominant model (i.e., D5S2011) as having the same mean; the meaningful genotypes being homozygous and heterozygous was a risk factor for the two types of asthma compared with each other. Six meaningful genotypes were shown in the recessive model (i.e., D2S323), that is, the meaningful genotypes being homozygous was a risk factor for the two types of asthma compared with each other. All odd ratios are either larger than or smaller than one.
Discrimination for two forms of asthma by genotype data Twenty-one of 36 significant STR markers were found on at least one meaningful genotype. Transformed binary data set contained information on 21 markers reduced by data transformation. Discrimination equation using the transformed binary data set was performed by logistic regression (Table 2 ). The combination equation of 11 markers that was generated by logistic regression without pro-selection can divide patients into two groups: high IgE (p >0.5) and normal IgE (p <0.5). The Stacey et al. (2001) cut-off point of 0.5 was chosen, which showed 0.84 specificity and 0.23 sensitivity by receiver operating characteristic (ROC) curve analysis. Misclassification rate was 0.189. The result implied that two type of asthma have a different genetic polymorphism background. The misclassification rate may be due to some asthmatics belonging to mixed type, or to other unrevealed genetic factors.
Marker to marker synergetic effect
To find the marker-to-marker synergetic effect in two forms of asthma, the p values of Fisher's exact test for every marker-marker genotype combination associated with IgE status was used. Results are reported in Table 3 . A p value less than 0.05 is presented in bold. The marker orders were dependent on their chromosome location and are rearranged here for effective visualization. The matrix is partitioned into two triangles indicated by bold type and one rectangle indicated by normal type. To make sure whether there was a correlation between every two markers, the odds ratio of marker-to-marker genotype combinations was applied. The odds ratios of combined and single markers are listed in Table 4 . Simulation using the resampling method was performed to evaluate the odds ratio generated by chance or not. The real correlation between two markers was maintained after resampling. On the other hand, the real correlation did not disappear due to different subgroups of total samples. For resampling, 152 subjects were randomly chosen from the 190 subjects and repeated 10,000 times. Table 5 displays the results of odds ratios after simulation. Markers D5S674, D6S1574, and D19S226 in the upper-left triangle combined with more than two markers had an increased odds ratio (OR < 0.14) compared with those with a single marker. In the lower-right triangle, markers D5S2011, D6S1573, and D9S286 combined with more than one other marker and had a significantly decreased odds ratio (OR > 7.1) compared with those with a single marker.
Discussion
According our investigation, 36 STR markers were significantly different between allergic and nonallergic asthma. Twenty-one of these 36 STR markers were found to have at least one meaningful genotype. Using an 11-marker combination equation generated by logistic regression and divided by cutoff points of p = 0.5, we clearly show that these two forms of asthma have different genetic polymorphism backgrounds. Markerto-marker synergetic effect and simulation resampling tests revealed D5S2011, D6D1573, and D9S286 were important loci in allergic asthma while D5S674, D6S1574, and D19S226 were important in nonallergic asthma, with odds ratio <0.14 and >7.1, respectively. The results implied several genes, not just one major gene, contribute asthmatic genotype and phenotype in our studied subjects. The STR markers, as multiallelic markers, always have more power to detect LD than do diallelic markers (such as SNPs) under otherwise equivalent conditions (Ott and Rabinowitz 1997; Chapman and Wijsman 1998) . Power equivalent to that achieved by a multiallelic screen can theoretically be achieved by use of a denser diallelic screen, but mapping panels of the necessary resolution are not currently available and may be difficult to achieve. Theoretically, existing sets of microsatellite data, if sufficiently dense, can make initial predictions about the level of short-range LD present in susceptibility regions identified by linkage studies. These predictions can be useful for planning the density of markers needed for fine-mapping experiments (Schulze et al. 2002) .
When analysis is restricted to members of reasonably well-defined ethnic or political groups, evidence of LD can frequently be found, with markers spanning the disease loci at 0.5-1.4 cM intervals (Wijsman 1997) . Examples are found in Japanese (Goddard et al. 1996) , Italians (Pandolfo et al. 1990 ), British (Votruba et al. 1998) , and Poles (Brzustowicz et al. 1993 ). According to the above literature, candidate genes mentioned by previous references were selected, surrounding significant markers within 1 Mb physical distance. They are listed in Table 6 . Several markers had no known candidate genes nearby. Candidate genes were being divided into some functionally related categories as response to environmental factors (such as CD14), inflammation (cytokines, cytokine receptors, chemokines), remodeling (FGF1, ADAMTS12, PDGFRA and epidermal growth factor), and others (transcription related genes, kinase). From another view, those candidate genes may imply or indicate that there is some biological pathway or mechanism related to asthma development, such as IL2RA, IL15RA, RAG1, and RAG2 in cytokine and signaling pathways related to immunodeficiencies (Schluns and Lefrancois 2003; Candotti et al. 2002) ; CD14 and Ly86 in innate recognition of lipopolysaccharides (Miyake 2003) ; and CCL17 and CCL12 correlated with the recruitment of specific leukocyte subsets expressing the receptors for those chemokines in asthma and other pulmonary diseases (D'Ambrosio et al. 2003) .
Our findings have clearly showed that, even in a very homogenous population, the susceptible genes for the concentration of serum IgE and responsive to environmental aeroallergens were quite different in asthmatic children. Although the difference of clinical manifestations between these two forms of asthma are not so prominent as in adult asthmatics, nonallergic asthmatic children tend to have a higher frequency of asthmatic attacks with more adherence to controlled medications and are also more prone to have airway remodeling than those with allergic asthma (Romanet-Manent et al. 2002; Inouye et al. 1985) . Our results have demonstrated that these two forms of asthma are governed by two different sets of susceptible genes that lead to common end results of eosinophilic bronchial inflammation found in all asthmatic patients. It is also strongly suggested that, in fact, allergic and nonallergic asthma are two different clinical entities that demand a different consideration and management in the prevention and treatment of childhood asthma.
